|
FAM175A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.838000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.102700E-03 |
| Normal-vs-Stage2 |
8.318400E-01 |
| Normal-vs-Stage3 |
1.150280E-02 |
| Normal-vs-Stage4 |
2.38760000004223E-06 |
| Stage1-vs-Stage2 |
1.899610E-01 |
| Stage1-vs-Stage3 |
2.83670000000846E-06 |
| Stage1-vs-Stage4 |
2.36889952098807E-10 |
| Stage2-vs-Stage3 |
1.158410E-01 |
| Stage2-vs-Stage4 |
5.356300E-03 |
| Stage3-vs-Stage4 |
6.330100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.015200E-01 |
| Normal-vs-AfricanAmerican |
5.278000E-03 |
| Normal-vs-Asian |
9.300200E-01 |
| Caucasian-vs-AfricanAmerican |
2.224800E-03 |
| Caucasian-vs-Asian |
9.927600E-01 |
| AfricanAmerican-vs-Asian |
2.408200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.556400E-01 |
| Normal-vs-Female |
9.687400E-01 |
| Male-vs-Female |
9.358600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.811600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.533000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.684400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.623400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.646200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.938200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.716200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.387600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.786200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.683000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.213800E-02 |
| Normal-vs-Grade 2 |
1.161210E-03 |
| Normal-vs-Grade 3 |
9.387800E-02 |
| Normal-vs-Grade 4 |
2.64600008570426E-10 |
| Grade 1-vs-Grade 2 |
5.393200E-01 |
| Grade 1-vs-Grade 3 |
1.422020E-02 |
| Grade 1-vs-Grade 4 |
3.25350000052183E-07 |
| Grade 2-vs-Grade 3 |
2.10379999999732E-05 |
| Grade 2-vs-Grade 4 |
1.62914126633495E-12 |
| Grade 3-vs-Grade 4 |
1.76050000000316E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.16979999920508E-08 |
| Normal-vs-ccB subtype |
2.30999999994985E-06 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.443200E-01 |
| Normal-vs-N1 |
2.22630003321456E-09 |
| N0-vs-N1 |
1.14979999998877E-06 |
|
|
